Award

Galeas At Home Bladder Cancer Genome Testing

NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)

This public procurement record has 2 releases in its history.

Award

11 Mar 2026 at 19:25

Award

04 Feb 2026 at 10:21

Summary of the contracting process

The NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, has awarded a contract to Informed Genomics Ltd for the delivery of Galeas At Home Bladder Cancer Genome Testing under the direct procurement method. The initiative involves up to 750 at-home bladder cancer genome tests, reporting results to a cloud-based platform, with the process supported by Hywel Dda, Aneurin Bevan, and Swansea Bay University Health Boards. The contract, valued at GBP 252,000, commenced on 9 March 2026 and will run until 8 September 2026. This procurement falls within the medical equipment category, addressing healthcare needs in various regions across Wales, and aims to enhance bladder cancer diagnosis through an innovative home-based method. The contract is awarded based on technical reasons due to Informed Genomics Ltd's unique offering of non-invasive home testing solutions.

This tender presents significant growth opportunities for businesses engaged in medical equipment and diagnostics. SMEs specialising in next-generation sequencing and cloud-based reporting platforms can leverage the demand for non-invasive diagnostic tools. The streamlined procurement process via direct award and the focus on innovative medical solutions highlight an effective entry point for research-focused enterprises and suppliers with expertise in genome testing and digital health solutions. This contract underscores the potential for businesses to develop partnerships with health boards and contribute to advancements in patient care pathways, notably in cancer diagnostics and treatment efficiency.

Find more tenders on our Open Data Platform.
How relevant is this notice?

Notice Title

Galeas At Home Bladder Cancer Genome Testing

Notice Description

Hywel Dda University Health Board (HDUHB), Aneurin Bevan University Health Board (ABUHB), and Swansea Bay University Health Board (SBUHB) have awarded a contract to Informed Genomics Ltd for the delivery of up to 750 at home bladder cancer genome tests (Galeas) as well as the reporting of results to a cloud-based platform. Cancer Research UK's data shows that bladder cancer is the 9th most common cause of cancer death in the UK, accounting for 3% of all new cancer cases in the UK, with around 2,800 new cases in females and 7,600 new cases for males every year (2017-2019). The NHS Wales National Optimal Pathway (NOP) for bladder cancer has been developed as part of the Single Cancer Pathway (SCP), which aims to establish consistent generic and site-specific pathways that describe all routes of entry onto the pathway from the point of suspicion (PoS) of cancer. Following PoS, a GP referral is made, or referrals are made as a result of incidental findings, ward referrals, or emergency presentation. Where blood is visible and non-visible in urine, patients are referred for testing, necessitating a diagnostic procedure as the first episode of care, typically a flexible cystoscopy procedure. Most diagnostic referrals are to rule out bladder cancer suspicion in patients, with an invasive flexible cystoscopy procedure being undertaken. Following the diagnostic pathway, where bladder cancer is confirmed, the patient will enter the treatment pathway. The Urology Clinical Implementation Network (CIN) has identified a provider in the marketplace, Informed Genomics Ltd., who offer an innovative genome testing kit (Galeas) that can identify bladder cancer through urine samples collected at home. GALEAS Bladder is a simple urine test for bladder cancer that delivers results equivalent to a cystoscopy. A completely non-invasive test, GALEAS Bladder is a sample-to-report urine test developed in partnership with University of Birmingham which uses next generation sequencing to interrogate somatic mutations found across all grades and stages, which detects bladder cancer. A sensitive diagnostic test, the GALEAS Bladder is equivalent to cystoscopy for all grades and stages of bladder cancer, including non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). Results are reported into a cloud based GALEAS software, providing clinicians with results digitally. This innovative test offers many benefits, including patient experience, where urine samples can be collected at home in a non-invasive manner, reducing the need to travel for invasive procedures. Patient outcomes will also be improved due to the reduced turnaround time for results (provided within one (1) week of receipt of sample). This timely receipt of diagnostic results will allow clinicians to make informed decisions on patient care and pathways, with treatment provided in a timely manner, reducing the risk of cancer progressing to further stages. Current figures suggest this will reduce current pathway by seven (7) weeks. HDUHB, ABUHB, and SBUHB will trial up to 750 tests to be called off over six (6) months. Volumes per Health Board are as follows: HDUHB 300 tests, ABUHB 200 tests, SBUHB 250 tests.

Procurement Information

Single suppliers technical reasons

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06468a
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/022076-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33100000 - Medical equipments

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£210,000 £100K-£500K
Contracts Value
£210,000 £100K-£500K

Notice Dates

Publication Date
11 Mar 20261 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
4 Feb 20262 months ago
Contract Period
9 Mar 2026 - 8 Sep 2026 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CARDIFF
Postcode
CF14 3UZ
Post Town
Cardiff
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
Not specified

Local Authority
Cardiff
Electoral Ward
Gabalfa
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
1
Supplier Name

INFORMED GENOMICS

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-06468a-2026-03-11T19:25:26Z",
    "date": "2026-03-11T19:25:26Z",
    "ocid": "ocds-h6vhtk-06468a",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PXWV-6492-CGMN",
            "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PXWV-6492-CGMN"
            },
            "address": {
                "streetAddress": "4-5 Charnwood Court,",
                "locality": "Cardiff",
                "postalCode": "CF14 3UZ",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKL22"
            },
            "contactPoint": {
                "name": "Sian John",
                "email": "sian.john4@wales.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
                "classifications": [
                    {
                        "id": "publicAuthoritySubCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - sub-central government"
                    },
                    {
                        "id": "GB-WLS",
                        "scheme": "UK_CA_DEVOLVED_REGULATIONS",
                        "description": "Welsh devolved regulations apply"
                    }
                ]
            }
        },
        {
            "id": "GB-PPON-PZXY-1897-VDDJ",
            "name": "Informed Genomics Ltd",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PZXY-1897-VDDJ"
            },
            "address": {
                "streetAddress": "11 Ridgeway",
                "locality": "Quinton, Birmingham",
                "postalCode": "B32 1AF",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKG31"
            },
            "contactPoint": {
                "email": "Gemma.Gerzon@nonacus.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme",
                "vcse": false,
                "publicServiceMissionOrganization": false,
                "shelteredWorkshop": false
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PXWV-6492-CGMN",
        "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
    },
    "tender": {
        "id": "P0431",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Galeas At Home Bladder Cancer Genome Testing",
        "description": "Hywel Dda University Health Board (HDUHB), Aneurin Bevan University Health Board (ABUHB), and Swansea Bay University Health Board (SBUHB) have awarded a contract to Informed Genomics Ltd for the delivery of up to 750 at home bladder cancer genome tests (Galeas) as well as the reporting of results to a cloud-based platform. Cancer Research UK's data shows that bladder cancer is the 9th most common cause of cancer death in the UK, accounting for 3% of all new cancer cases in the UK, with around 2,800 new cases in females and 7,600 new cases for males every year (2017-2019). The NHS Wales National Optimal Pathway (NOP) for bladder cancer has been developed as part of the Single Cancer Pathway (SCP), which aims to establish consistent generic and site-specific pathways that describe all routes of entry onto the pathway from the point of suspicion (PoS) of cancer. Following PoS, a GP referral is made, or referrals are made as a result of incidental findings, ward referrals, or emergency presentation. Where blood is visible and non-visible in urine, patients are referred for testing, necessitating a diagnostic procedure as the first episode of care, typically a flexible cystoscopy procedure. Most diagnostic referrals are to rule out bladder cancer suspicion in patients, with an invasive flexible cystoscopy procedure being undertaken. Following the diagnostic pathway, where bladder cancer is confirmed, the patient will enter the treatment pathway. The Urology Clinical Implementation Network (CIN) has identified a provider in the marketplace, Informed Genomics Ltd., who offer an innovative genome testing kit (Galeas) that can identify bladder cancer through urine samples collected at home. GALEAS Bladder is a simple urine test for bladder cancer that delivers results equivalent to a cystoscopy. A completely non-invasive test, GALEAS Bladder is a sample-to-report urine test developed in partnership with University of Birmingham which uses next generation sequencing to interrogate somatic mutations found across all grades and stages, which detects bladder cancer. A sensitive diagnostic test, the GALEAS Bladder is equivalent to cystoscopy for all grades and stages of bladder cancer, including non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). Results are reported into a cloud based GALEAS software, providing clinicians with results digitally. This innovative test offers many benefits, including patient experience, where urine samples can be collected at home in a non-invasive manner, reducing the need to travel for invasive procedures. Patient outcomes will also be improved due to the reduced turnaround time for results (provided within one (1) week of receipt of sample). This timely receipt of diagnostic results will allow clinicians to make informed decisions on patient care and pathways, with treatment provided in a timely manner, reducing the risk of cancer progressing to further stages. Current figures suggest this will reduce current pathway by seven (7) weeks. HDUHB, ABUHB, and SBUHB will trial up to 750 tests to be called off over six (6) months. Volumes per Health Board are as follows: HDUHB 300 tests, ABUHB 200 tests, SBUHB 250 tests.",
        "status": "complete",
        "procurementMethod": "direct",
        "procurementMethodDetails": "Direct award",
        "procurementMethodRationale": "Single suppliers technical reasons",
        "lots": [
            {
                "id": "1",
                "status": "complete",
                "suitability": {
                    "sme": true
                }
            }
        ],
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest",
                "description": "Not published"
            }
        ],
        "riskDetails": "Diagnosis Turnaround: Turnaround form receipt of sample to receipt of report must be within one (1) week. Sample and Reporting Throughput: Supplier must meet minimum weekly throughput Costs: Cost of Galeas test must remain equal or under the published NHS Payment Scheme costs of a flexible cystoscopy (as updated in line with published NHS Payment Scheme)",
        "procurementMethodRationaleClassifications": [
            {
                "id": "singleSuppliersTechnicalReasons"
            }
        ]
    },
    "awards": [
        {
            "id": "1",
            "title": "Galeas At Home Bladder Cancer Genome Testing",
            "status": "active",
            "value": {
                "amountGross": 252000,
                "amount": 210000,
                "currency": "GBP"
            },
            "mainProcurementCategory": "goods",
            "aboveThreshold": true,
            "suppliers": [
                {
                    "id": "GB-PPON-PZXY-1897-VDDJ",
                    "name": "Informed Genomics Ltd"
                }
            ],
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "33100000",
                            "description": "Medical equipments"
                        }
                    ],
                    "deliveryAddresses": [
                        {
                            "region": "UKL14",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKL18",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKL21",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKL21",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKL14",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKL18",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "contractPeriod": {
                "startDate": "2026-02-16T00:00:00+00:00",
                "endDate": "2026-08-31T23:59:59+01:00"
            },
            "relatedLots": [
                "1"
            ],
            "documents": [
                {
                    "id": "009819-2026",
                    "documentType": "awardNotice",
                    "noticeType": "UK5",
                    "description": "Transparency notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/009819-2026",
                    "datePublished": "2026-02-04T10:21:04Z",
                    "format": "text/html"
                }
            ],
            "milestones": [
                {
                    "id": "1",
                    "type": "futureSignatureDate",
                    "dueDate": "2026-02-16T23:59:59+00:00",
                    "status": "scheduled"
                }
            ]
        }
    ],
    "language": "en",
    "contracts": [
        {
            "id": "1",
            "awardID": "1",
            "title": "Galeas At Home Bladder Cancer Genome Testing",
            "status": "active",
            "period": {
                "startDate": "2026-03-09T00:00:00+00:00",
                "endDate": "2026-09-08T23:59:59+01:00"
            },
            "value": {
                "amountGross": 252000,
                "amount": 210000,
                "currency": "GBP"
            },
            "aboveThreshold": true,
            "dateSigned": "2026-03-09T00:00:00+00:00",
            "agreedMetrics": [
                {
                    "id": "1",
                    "title": "Service Level Agreement KPIs",
                    "observations": [
                        {
                            "id": "frequency",
                            "period": {
                                "durationInMonths": 1
                            }
                        }
                    ]
                }
            ],
            "documents": [
                {
                    "id": "022076-2026",
                    "documentType": "contractNotice",
                    "noticeType": "UK7",
                    "description": "Contract details notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/022076-2026",
                    "datePublished": "2026-03-11T19:25:26Z",
                    "format": "text/html"
                }
            ]
        }
    ]
}